It has been demonstrated that administration of an interleukin-l receptor antagonist protein (IL-lra) reduces isch emic brain injury; however, the detrimental mechanism initi ated by interleukin-l (IL-I) in ischemic brain injury is unclear, In this study, we used mice that were transfected to overexpress human IL-lra to elucidate the role of IL-I in the activation of the inflammatory response after middle cerebral artery occlu sion (MeAO), Myeloperoxidase (MPO) activity and immuno histostaining were used as a marker of polymorphonuclear leu kocytes (PMNL) infiltration, Adenoviral vector (l x 10 9 par ticles) was administered by injection into the right lateral ventricle in mice, Five days later, MeAO was performed on the mice using a suture technique, Permanent MeAO was achieved for 24 hours in the Ad,RSY IL-/ ra-transfected, Ad,RSY lacZ transfected, and saline (control) mice, Myeloperoxidase activ ity was quantified in each region and localization of MPO was determined by immunohistochemistry, After 2 hours of MeAO, the surface cerebral blood flow was reduced to 13,5% ± 3A%, 10,75% ± 2.6%, and \0,9% ± 2.6% of baseline in the ischemic hemisphere in Ad.RSV lL-l ra-transfected, Ad.RSV-Polymorphonuclear leukocytes (PMNL) have been proposed to contribute to the pathogenesis of cerebral ischemia and stroke since the late 1960s (Somas et aI., 1972). Delayed accumulation of PMNL and monocytes Abbreviations used: IL-I, interleukin-l; IL-Ira, IL-l receptor an tagonist protein; Ad.RSV IL-J ra, replication-defecti ve adenovirus vec tor that transduces TL-I ra cDNA; Ad.RSV lacZ, replication-deficient adenovirus vector that transduces Escherichia coli l3-galactosidase gene; LDF, laser�Doppler flowmeter; MCAO, middle cerebral artery occlusion; MPO, myeloperoxidase; PMNL, polymorphonuclear leuko cytes.
lacZ-transfected, and saline-treated mice, respectively, The MPO activity in the ischemic hemisphere in the Ad,RSVlacZ group was similar to that in the saline control group (cortex: OAO ± 0.22 versus 0,33 ± 0. 11; basal ganglia: OA6 ± 0.23 versus OA9 ± 0,17; P > 0.05); however, it was significantly reduced in the Ad.RSV IL-l ra group (cortex: 0.18 ± 0.07; basal ganglia: 0.26 ± 0.15; P < 0.05). Myeloperoxidase immunohis tochemistry showed that the massive accumulation of MPO positive cells in the ischemic cortex, striatum, and corpus cal losum regions was greatly attenuated in Ad,RSYIL-Jra transfected mice, Our results indicate that Ad.RSY lL-1 ra transfected mice provide a useful tool to study the mechanism of action of IL-I. The MPO activity assay and immunostaining after 24 hours of focal ischemia were significantly reduced in IL-I ra gene-transfected mice, suggesting that IL-I may play an important role in the activation of inflammatory cells during focal cerebral ischemia. Key Words: lmmunohistochemis try-Ischemia-Mice-Middle cerebral artery occlusion Myeloperoxidase-Neutrophil. after experimental stroke was demonstrated in 1974 (Garcia and Kamijyo, 1974) . Using indium-Ill-labeled autologous PMNL in a model of air embolism-induced cerebral ischemia in dogs, Hallenbeck et al. (1986) con firmed that PMNL accumulate progressively during the first 4 hours of reperfusion. Much of the research litera ture has demonstrated that brain injury caused by isch emia and reperfusion can be attenuated by PMNL deple tion (del Zoppo et aI., 1991; Dutka et aI., 1989; Shiga et aI., 1991) , Schurer et al. (1990) showed that antineutro phil serum blocks brain injury after reversible bilateral carotid artery occlusion in rats. Recently, Jiang et al. (1995) reported a neutrophil inhibitory factor, a 41-kDa recombinant glycoprotein, which has a remarkable neu roprotecti ve effect in rat focal ischemia.
Inflammatory cell infiltration can be quantified by us-ing an assay of myeloperoxidase (MPO) activity, an en zyme found within the azurophilic granules of PMNL (Bradley et aI., 1982) . The MPO activity assay has been considered to be a reliable method to estimate neutrophil infiltration into inflamed tissue, including ischemic brain (Allan et aI., 1985; Barone et aI., 1991; Change et aI., 1986; Goldblum et aI., 1985; Krawisz et aI., 1984; Smith et aI., 1988) . Myeloperoxidase immunohistochemistry has demonstrated that MPO-immunopositive cells are greatly increased after focal ischemia in rat brain (Jiang et aI., 1995) . However, this enzyme assay and immuno staining method has not previously been used to quantify PMNL infiltration in the mouse middle cerebral artery occlusion (MCAO) model. Depletion of circulating neu trophil not only inhibits the increase of MPO activity in the ischemic brain tissue but also attenuates postischemic brain injury (Matsuo et aI., 1994) .
Interleukin-l (IL-l) is a potent inflammatory mediator that is also known to be a cofactor in the inflammatory reaction. Constitutive expression of IL-l in normal brain is low; however, it is markedly increased after transient forebrain ischemia (Blatteis, 1992; Breder et aI., 1988) , injection of bacterial endotoxin (Ban et aI., 1991; Clark et aI., 1991; Higgins and Olschowka, 1991) , local brain injury (Giulian et aI., 1988) , administration of excito toxic agents (Minami et aI., 1990) , and restraint stress (Minami et aI., 1991) . Brain IL-l participates directly in ischemic and traumatic brain injury (Relton and Rothwell, 1992) . Although central or systemic adminis tration of an IL-l receptor antagonist (IL-l ra) reduces ischemic brain injury in short-term experiments, provid ing and maintaining an effective concentration of IL-lra in the brain for a long period to treat these diseases may be difficult (Garcia et aI., 1995; Relton and Rothwell, 1992) . lnterleukin-l ra, a human monocyte-derived 17 -kDa polypeptide, was first discovered in a tumoral cell line (human myelomonocytic line, U937) (Carter et aI., 1990) . Interleukin-lra is usually produced by the same cells as IL-l in the normal brain (Andersson et aI., 1992; Dinarello and Thompson, 1991; Garcia et aI., 1995) . In terleukin-lra can inhibit many actions of IL-I in vivo and in vitro (Eisenberg et aI., 1991) . In our previous experi ments with adenovirus-injected brain, however, it ap pears that the protection from ischemia is caused by IL Ira produced by the ependymal cells. These seem to be the primary cells infected after ventricular infusion of adenovirus as indicated by experiments using lacZ as a marker (Yang et aI., 1997) . Relatively few cortical cells were infected.
Gene transfer provides a useful tool to study the mechanisms of the action of IL-l f3 in vivo. Overexpres sion of IL-lra using a replication-deficient adenovirus vector that transduces IL-Ira cDNA (Ad.RSVIL-Ira) at-tenuated ischemic brain injury in both rat and mouse models of focal cerebral ischemia (Betz et aI., 1995; Yang et aI., 1997) . However, the relationship between inhibiting the action of IL-l and reducing the ischemic inflammatory response has not been well studied. The objectives of the present study are to determine (1) whether overexpression of IL-l ra in the mouse brain will reduce the ischemic inflammatory response in the brain, and (2) whether these effects are accompanied by detect able decreases in neutrophil sequestration in the ischemic territory.
MATERIALS AND METHODS

Adenoviral gene-transfected mouse brain
The production of Ad.RSVIL-ira and replication-deficient adenovirus vector that transduces Escherichia coli (3galactosidase gene (Ad.RSVlacZ) vectors has been described previously (Roessler et a!., 1995) . Both viruses use the Rous Sarcoma virus (RSV) promoter to drive gene transcription. The Ad.RSVlacZ serves as a control virus carrying a gene not ex pected to alter cerebral injury.
Procedures for the use of laboratory animals were approved by the institutional animal care and use committee. Mature male CD-I mice (Charles River) weighing 30 to 35 g were anesthetized with 4% chloral hydrate (400 mg/kg, intraperito neally). After induction of the anesthesia, the mice were placed in a stereotactic frame (Kopf Model 92 1, David Kopf Instru ments, Tujunga, CA, U.S.A.) while a burr hole was drilled to the pericranium I mm lateral to the sagittal suture and 1 mm posterior to the coronal suture. A I O-f.LL Hamilton syringe was stereotactically inserted into the lateral ventricle about 2.5 mm under the cortex. One microliter of adenoviral suspension con taining 1 x 10 1 2 particles/mL was injected into the lateral ven tricle at a rate of 0.2 f.LLlminute. The needle was then with drawn over the course of 5 minutes, the hole was sealed with bone wax, the wound was closed with suture, and the animals were allowed to recover in the cage.
To control for the possibility that the adenoviral vectors might have caused acute inflammatory reaction in the brain, three groups of mice (n = 9 in each group) received the same volume of Ad.RSVIL-lra or Ad.RSVlacZ or saline (control) injection intraventricularly. They were then sacrificed at 1, 3, and 5 days after adenovirus injection. Brains were removed and frozen immediately in 2-methylbutane at -42°C. Cryostat sec tions (lO-f.Lm thickness) were cut at -15°C and mounted on slides. The sections were dried with gentle cool air and stained with hematoxylin-eosin. The inflammatory effect of the adeno virus injection in these groups has been examined.
Production of focal ischemia
Five days after administration of adenovirus (either Ad.RSVlL-lra or Ad.RSVlacZ) or saline (control), three groups of mice (8 to 10 mice in each group) were reanesthe tized with 1.5% isoflurane in 70% N20 and 30% O2, The animals were ventilated to maintain Pa02 at 90 mm Hg or above. The body temperature was maintained at 37.0° ± 0.5°C using a heating pad during the operation. The middle cerebral artery was permanently occluded for 24 hours in Ad.RSVIL ira, Ad.RSVlacZ, and saline control mice. The MCAO method was described in our previous studies (Yang et aI., 1994) .
Brietly. the left common carotid artery was exposed through a midline incision. The internal carotid artery was then isolat, .I and its branch, the pterygopalatine artery, was ligated close to its origin. Then a 2-cm length of 5-0 rounded-tip Dermalon suture was advanced from the external carotid artery through the common carotid artery and then up to the internal carotid artery for a distance of 11.0 ± 0.5 mm.
Laser-Doppler flowmeter
A laser-Doppler flowmetry (LDF) monitor (Model BPM 2 System, Vasamedics Inc., St. Paul. MN. U.S.A.) equipped with a small-caliber probe of 0.7 mm diameter (P-433, Vasamedics Inc.) was used to measure local cerebral blood flow (CBF). Because the mouse skull is very thin. the LDF probe was placed over intact pericranium and readings were obtained through an intact skull. The probe was gently lowered onto the pericranium 3.5 mm lateral to the sagittal suture and I mm posterior to the coronal suture. Baseline LDF recordings were made 10 minutes before MCAO. Temperature was maintained at 37.0° ± O.SOC using a heating lamp and heating pad. Warmed saline was slowly rinsed around the probe during the experiments (Dirnagl et aI., 1989) . Continuous digital display LDF values were av eraged for 5-second intervals and were recorded every 30 min utes during the first 2 hours of MCAO. Mice were allowed to awaken in the cage after the last surface blood flow measure ment. The CBF values were then calculated and expressed as percentages of baseline values (Yang et al.. 1994) .
Myeloperoxidase assay
The mouse was reanesthetized with 4% chloral hydrate and perfused transcardially with isotonic saline (a pressure of 100 mm Hg, at 25°C) before brain removal to flush all blood com ponents from the vasculature. An 8-mm slice of the forebrain between the olfactory bulbs and the cortical-cerebellar junction was sectioned and dissected into four separate segments (the wet weight of each segment was �80 mg): (I) ischemic cortex;
(2) ischemic basal ganglia; (3) contralateral cortex; and (4) contralateral basal ganglia. The four forebrain segments were then immediately frozen at -70°C. Tissue segments were thawed on ice, weighed. and homogenized (Model PTIl035 Polytron, Brinkman Instruments Inc., Westburg, NY, U.S.A.) in 4 mL of 50 mmol/L Tris-HCI. pH 7.4, at 4°C. Samples were added to 20 mL 5 mmol/L phosphate buffer, pH 6.0, at 4°C. homogenized using a tissumizer homogenizer (Tekmar Co .. Cincinnati, OH. U.S.A.: three on/off cycles at 5-second inter vals). and centrifuged at 30,000g for 30 minutes at 4°C. The supernatant was discarded and the pellet was washed again as described above. After decanting the supernatant, the pellet was extracted by suspension in 0.5% hexadecyl trimethylammonium bromide (HTAB, Sigma Chemical CO., St. Louis, MO, U.S.A.) in 50 mmol/L potassium phosphate buffer at 25°C for approximately 2 minutes at an original tissue wet weight to volume ratio of I :2. The samples were immedi ately frozen on dry ice. Freeze and thaw cycles were then performed three times with sonications for 10 seconds at 25°C between cycles. After the last sonication, the samples were incubated at 4°C for 20 minutes and centrifuged at 12,500g for 15 minutes at 4°C. The supernatants (100 fLL) were mixed with 100 fLL of 50 mmol!L phosphate buffer, pH 6.0, containing o-dianisident dihydrochloride (0. 167 mg/mL; Sigma Chemical Co.) and hydrogen peroxide (0.005%). Absorbency was mea sured at 460 nm using a Beckman DU-7 spectrophotometer with kinetic analysis capability with the absorbance recorded at 15-second intervals over a 3-minute period. One unit of MPO activity is defined as the amount that degrades I mole of per-J Cereb Blood Flow Metah. Vol. 18. No.8, 1998 oxide/minute at 25°C. Myeloperoxidase activity for each tissue sa .. ,pie was nornalized on the basis of grams wet weight tissue.
Myeloperoxidase immunohistochemistry
Three groups of mice (n = 6 in each group) were sacrificed 24 hours after MCAO by decapitation. Brains were removed and frozen immediately in 2-methylbutane at -42°C for 5 min utes. Cryostat sections (20-fLm thickness) were cut at -15°C and mounted on slides. The sections were dried by gentle cool air from a dryer for a short period and kept in -20°C until use. Immunostaining was performed on the same day as sectioning. The sections were first fixed with Carnoy fixation (60% metha nol, 30% chloroform, and 10% acetate) for 20 minutes, then rinsed three times for 5 minutes with 0. 1 mollL phosphate buffered saline (pH 7.4, Sigma Chemical Co.). Nonspecific binding was blocked by using 10% r rmal ;oa: semm for 30 minutes at room temperature. The sections were incubated in the I :400 dilution of rabbit polyclonal anti-MPO primary an tibody (A398, DAKO Inc., Carpinteria, CA, U.S.A.) overnight at 4°C. After treatment with 1% H20 2 in 30%170% methanol! phosphate-buffered saline solution, the sections were then in cubated with biotinylated goat anti-rabbit secondary antibody for 90 minutes at room temperature followed by an ABC pro cess (ABC-Elite kit, Vector, Burlingame, CA, U.S.A.) and fi nally treated with stable 3,3' -diaminobenzidine tetrahydrochlo ride (DAB, Research Genetics) as a peroxidase substrate. The negative control was also carried out using the same concen tration of normal rabbit immunoglobulin instead of primary antibody.
Statistical analysis
All data are expressed as mean and standard deviation. Para metric data among the Ad.RSVIL-lra, Ad.RSVlacZ, and saline control groups were evaluated using analysis of variance and two-tailed Student's t test with Bonferroni adjustment. A prob ability value of less than 5% was considered statistically sig nificant.
RESULTS
Neither Ad.RSVIL-lra nor Ad.RSVlacZ recombinant virus had any effect on weight gain during the 5 days after virus injection. No neurologic deficits were ob served in either Ad.RSVIL-lra-or Ad.RSVlacZ transfected mice. The rectal body temperature range was 37.0° ± 0.5°C. Hematoxylin-eosin stained sections were scored for the degree of cellular reaction around the needle tract 1 to 5 days after Ad.RSVIL-lra, Ad.RSV lacZ, or saline intraventricular injection. All three groups of mice had mild reactions around the needle tract ( Fig.  1 A-C ). There were mild host reactions near and inside the ipsilateral ventricle. Host reactions to the adenoviral vectors were similar regardless of the encoded trans gene. These initial data suggest that central adenoviral injec tion does not substantially change physiologic param eters in mice.
Cerebral blood flow
Surface CBF measurements from mice undergoing MCAO are depicted in Fig. 2 . In all three groups the CBF measured in the contralateral hemisphere during MCAO was about 100% of preocc1usion (baseline) flow. The surface CBF in the ipsilateral hemisphere, however, was reduced immediately after introduction of the suture. During the first 2 hours of MCAO, the blood flow in Ad.RSV IL-l ra-transfected, Ad. RS V lacZ-transfected, and saline-treated mice was 13.5% ± 3.4%, 10.7% ± 2.6%, and 10.9% ± 2.6% of baseline, respectively (n = 8 to 10, not significantly different from each other, P> 0.05). The CBF measurement was necessary to confirm that ischemia occurred focally, rather than globally, be cause systemic hypotension or intracranial hypertension may develop.
Myeloperoxidase activity
Four brain regions (contralateral cortex, contralateral basal ganglia, ipsilateral cortex, and basal ganglia) were assayed for MPO activity, an indicator of neutrophil ac cumulation. There were no significant differences in MPO activity among the four regions of the sham-operated animals with values of between 0.023 and 0.065 units/g wet tissue. Myeloperoxidase activities in both cortex and basal ganglia of the contralateral hemisphere in the Ad.RSV fL-l ra-transfected, Ad.RSV lacZ transfected, and saline-treated mice were slightly in creased, but there were no significant differences among the groups (P > 0.05). Compared with the contralateral side, however, the MPO activity was significantly in creased in both the ipsilateral cortex and basal ganglia in the Ad.RSVlacZ-transfected (0.40 ± 0.22 and 0.46 ± 0. 23 units/g) and saline-treated (0.33 ± 0.11 and 0.49 ± 0.17 units/g) mice (P < 0.05, Fig. 3 ). The increases of MPO activity in the ipsilateral hemisphere in the Ad.RSVlacZ transfected and the saline-treated groups were similar. The highest level of MPO activity was found in the ip silateral basal ganglia region. Compared with the Ad.RSVlacZ-transfected and the saline-treated mice, however, the MPO activity was significantly inhibited in the Ad.RSVlL-lra-transfected group both in the cortex and the basal ganglia region (0.18 ± 0.07 and 0.26 ± 0. 15 units/g versus Ad.RSV lacZ-transfected and saline treated groups, P < 0.05, Fig. 3 ).
Myeloperoxidase immunohistochemistry
In the Ad.RSV lacZ-transfected and saline-treated mice, immunohistochemistry showed that MPO immunoreactive cells distributed in large quantities in and around the ischemic lesion. Positive cells were pre sent in both ipsilateral striatum and cortex, and in the ipsilateral corpus callosum. Some MPO-positive cells were found in the contralateral hemisphere, especially in the corpus callosum region. All positive cells were either round or oval in morphology with multiple nuclei. This indicates that the increased MPO staining is really caused by the accumulation of PMNL (Fig. 4) . The quan tity of MPO-immunopositive cells in the ipsilateral hemisphere in the Ad.RSVlacZ-transfected group ap peared similar to that in the saline-treated group; how ever, the number of immunopositive cells was greatly reduced in the ipsilateral hemisphere in Ad.RSV IL-J ra transfected animals. The distribution of MPO immuno staining paralleled the results on MPO activity in each group.
DISCUSSION
In the present study, neutrophil accumulation was quantified by MPO activity assay. Myeloperoxidase measurement as a marker of inflammatory cell infiltra tion has proven to be of value in the brain (Barone et aI., 1992; Jiang et aI., 1995) . Barone et ai. (199 1) demon strated that an accumulation of neutrophils can be iden tified histologically and quantified using the MPO activ ity assay in spontaneously hypertensive rats after tempo rary MCAO. Using a suture MCAO model, Matsuo et al. (Matsuo et aI., 1994) found that MPO activity was sig nificantly increased in both cortex and caudate putamen, and this was maintained until 72 hours after reperfusion. Our study demonstrates that MPO activity is a sensitive and reproducible marker in small animal tissue such as the mouse brain. The results indicate that 24 hours of permanent MCAO in mice provides sufficient stimula tion to induce accumulation of neutrophils in the isch emic tissue with MPO activity being significantly in creased in the Ad.RSVlacZ-transfected and saline treated mice, especially in the basal ganglia region.
Myeloperoxidase immunostaining showed similar re sults, with MPO-positive cells increasing mainly in isch emic basal ganglia, then cortex, and a few in the contra lateral hemisphere (Fig. 4) . The increase of PMNL in the J Cereb Blood Flow Metab, Vol. Iii, No.8, 1998 ischemic core area suggests the inflammatory response occurs in areas of the lowest blood flow because the blood supply to the ischemic core region is very poor in this model. The LDF showed that surface CBF in the ischemic hemisphere remained at only 10% to 15% of baseline. Our previous study using this suture MCAO model showed the lesion in the basal ganglia was more severe than in the cortex (Yang et aI., 1994) .
The results of our study confirm and extend our pre vious findings, and show that the intraventricular admin istration of Ad.RSV IL-I ra resulted in a remarkable in hibition of PMNL accumulation after MCAO in mice ( Fig. 3) . At present, little is known about the mechanisms of action of IL-l in acute ischemic brain injury; however, from the known action of IL-l in brain, several possi bilities can be considered. Generally, the proposed mechanisms of brain injury produced by IL-l relate to its proinflammatory and immunologic properties (Dinarello, 1991) . The proinflammatory effects of IL-I include leu kocytosis, increased expression of endothelial cell adhe sion molecules, and neutrophil tissue infiltration even in the low picomolar range. Polymorphonuclear leukocytes may actively participate in the brain injury that develops after MCAO. Release of IL-l during cerebral ischemia may stimulate the synthesis of other cytokines (Hu et aI. , 1994) . These cytokines share many central actions with IL-l, and any increase of these cytokines could in tum exacerbate brain injury (Mori et aI. , 1992) . Interleukin-l is a potent activator of excitatory amino acid and nitric oxide release (Rothwell, 1991) . These substances have been proposed as important mediators of ischemic dam age (Farooqui and Horrocks, 1992) . It is unknown whether IL-l produces neuronal death directly or exac-. .
MYELOPEROXIDASE IN FOCAL ISCHEMIC MICE
Ad.RSVIL-lra Ad.RSVlacZ erbates other forms of damage, or both (Quagliarello et aI., 1991) . Interleukin-l could influence neuronal sur vival in vivo through indirect effects on microglia. Ex posure of cultured neurons to activated microglia results in rapid cell death, which appears to be caused by the release of excitatory amino acids from the microglia (Piani et aI., 1991) . Araujo and Cotman (1990) reported that exposure of cultured neurons to IL-l results in neu rotoxicity, although the relevance of these data to a pos sible in vivo role is difficult to prove. Our studies provide evidence that IL-lra inhibits the accumulation of MPO during focal ischemia. Although the beneficial effect that IL-lra provided is clear during MCAO, how the IL-l ra plays a role in the ischemic event must be further studied. We chose Ad.RSVlacZ gene-transfected mice as a control virus group because it shares the same adenoviral vector as Ad.RSV IL-J ra and both are capable of produc ing protein. Several published papers have demonstrated that the use of an adena viral control is necessary (Horel lou et aI., 1997; Viola et aI., 1995) , although our pub lished data show that the brain injury after permanent MCAO is similar between Ad.RSVlacZ-transfected and saline-treated groups (Betz et aI., 1996) suggesting that .he adenovirus does not by itself protect the brain from injury. The only difference between the Ad.RSVIL-Ira transfected and the Ad.RSV lacZ-transfected control mice is the nature of the protein produced. Although it is most likely that the effects of IL-J ra on brain injury are caused by its actions as an IL-l inhibitor, IL-I ra is a mammalian proteill-ohereas lacZ is bacterial. The ques tion of whether there may be intrinsic differences be tween the effects of mammalian and bacterial protein on brain injury awaits the development of vectors express ing mutant mammalian proteins with no biologic activ ity.
In summary, our results demonstrated that ischemic brain injury is attenuated in Ad.RSV IL-J ra-transfected mice, which is related to the reduction of MPO activity. Our study suggests that IL-l may play an important role in the activation of inflammatory cells during focal ce rebral ischemia.
